CONMED (CNMD) to Release Quarterly Earnings on Wednesday

CONMED (NYSE:CNMD) will likely be issuing its quarterly earnings data after the market closes on Wednesday, February 5th. Analysts expect the company to announce earnings of $1.20 per share and revenue of $341.05 million for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

CONMED Stock Performance

Shares of NYSE:CNMD opened at $71.23 on Tuesday. The company has a market capitalization of $2.20 billion, a price-to-earnings ratio of 16.92, a P/E/G ratio of 1.04 and a beta of 1.47. The firm’s 50 day simple moving average is $70.64 and its 200 day simple moving average is $70.17. The company has a debt-to-equity ratio of 1.01, a current ratio of 2.27 and a quick ratio of 1.06. CONMED has a fifty-two week low of $61.05 and a fifty-two week high of $88.60.

CONMED Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 3rd. Investors of record on Friday, December 20th were paid a dividend of $0.20 per share. The ex-dividend date was Friday, December 20th. This represents a $0.80 dividend on an annualized basis and a yield of 1.12%. CONMED’s payout ratio is 19.00%.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on CNMD shares. Needham & Company LLC reissued a “buy” rating and set a $97.00 target price on shares of CONMED in a research note on Thursday, October 31st. StockNews.com cut shares of CONMED from a “buy” rating to a “hold” rating in a research note on Friday, November 8th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $79.80.

CONMED Company Profile

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries.